Sign inGet started

White Lauren

Insider CIK 1864430 · CCCC Chief Financial Officer · SPTX Chief Financial Officer · IMGN SVP, CFO AND PFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SPTX Seaport Therapeutics, Inc. C Conversion deriv2026-05-042026-05-0421,052— $00SEC↗
SPTX Seaport Therapeutics, Inc. C Conversion2026-05-042026-05-046,702— $06,702SEC↗
SPTX Seaport Therapeutics, Inc. A Award deriv2026-04-302026-05-0463,680— $063,680SEC↗
IMGN ImmunoGen, Inc. D To issuer deriv2024-02-122024-02-1219,519— $00SEC↗
IMGN ImmunoGen, Inc. D To issuer deriv2024-02-122024-02-1251,625— $00SEC↗
IMGN ImmunoGen, Inc. D To issuer deriv2024-02-122024-02-12295,975— $00SEC↗
IMGN ImmunoGen, Inc. A Award deriv2024-02-012024-02-0519,519— $019,519SEC↗
IMGN ImmunoGen, Inc. A Award deriv2023-09-182023-09-1951,625— $051,625SEC↗
IMGN ImmunoGen, Inc. A Award deriv2023-09-182023-09-19295,975— $0295,975SEC↗
CCCC C4 Therapeutics, Inc. M Exercise deriv2023-08-302023-08-312,250— $016,500SEC↗
CCCC C4 Therapeutics, Inc. F Tax w/h2023-08-302023-08-31661$2.93 $1.9K32,686SEC↗
CCCC C4 Therapeutics, Inc. M Exercise2023-08-302023-08-312,250— $033,347SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2023-02-132023-02-15125,000— $0125,000SEC↗
CCCC C4 Therapeutics, Inc. A Award2023-02-132023-02-1526,000— $031,097SEC↗
CCCC C4 Therapeutics, Inc. M Exercise deriv2023-01-302023-02-013,750— $018,750SEC↗
CCCC C4 Therapeutics, Inc. M Exercise2023-01-302023-02-013,750— $06,398SEC↗
CCCC C4 Therapeutics, Inc. F Tax w/h2023-01-302023-02-011,301$7.78 $10.1K5,097SEC↗
CCCC C4 Therapeutics, Inc. F Tax w/h2022-05-262022-06-141,102$7.01 $7.7K2,648SEC↗
CCCC C4 Therapeutics, Inc. M Exercise deriv2022-05-252022-05-273,750— $022,500SEC↗
CCCC C4 Therapeutics, Inc. M Exercise2022-05-252022-05-273,750— $03,750SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2022-02-142022-02-16100,000— $0100,000SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2022-02-142022-02-1626,250— $026,250SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2021-06-212021-06-21136,000— $0136,000SEC↗